Related Experiment Video
Updated: Apr 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Azacitidine-Induced Interstitial Pneumonitis.
Benjamin Verriere1, Vanessa Ferreira, Eric Denis
11Pharmacy Department, Antibes Hospital, France; 2Department of Internal Medicine, Antibes Hospital, Antibes, France; and 3Laboratory Department, Antibes Hospital, Antibes, France.
Azacitidine treats certain leukemias but can cause serious lung issues. This case highlights azacitidine-induced interstitial pneumonitis as a rare but significant adverse event in acute myeloid leukemia patients.
Area of Science:
- Oncology
- Pharmacology
- Pulmonology
Background:
- Azacitidine is a key treatment for myelodysplastic syndromes and acute myeloid leukemia.
- Common adverse events include hematotoxicity and infections.
- Interstitial pneumonitis is not widely recognized as a significant azacitidine side effect.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11:07Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
Published on: July 6, 2019
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Acute Respiratory Failure-III
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Atypical Pneumonia
Acute Respiratory Failure-IV